specificity cas9 protein Search Results


99
Integrated DNA Technologies specificity cas9 protein
OTX2 H230L had no abnormal phenotype, and C-terminal variants are tolerated. (A) <t>CRISPR/Cas9</t> generated Otx2 H230L and multiple by-product variants. (B) Otx2 H230L had no obvious phenotype in either the pituitary gland or the eye. Otx2 L219fs*17 showed anophthalmia/microphthalmia but, however, showed similar pituitary morphology to WT animals. Arrows and arrowheads indicate the pituitary gland and optic nerve, respectively. (C) HE staining of eyes of adult mice. Otx2 H230L had normal eyes, but the retina of Otx2 L219fs*17 was thin. (D, E and F) Pituitary histology of P0 mice. (D) HE staining, (E) GH staining, and (F) LH staining were similar between genotypes.
Specificity Cas9 Protein, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc08437083-77-9-14?v=Integrated+DNA+Technologies
Average 99 stars, based on 1 article reviews
specificity cas9 protein - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

93
Addgene inc specificity cas9 enzyme
Western blot analysis of BDH2 expression in four Bdh2 -deficient HEK293T clonal cell lines ( Bdh2 -KO) and WT HEK293T cells (WT). The KO clonal cell lines (A12, A15, B9, and B13) were generated by the <t>CRISPR–Cas9</t> gene-inactivation procedure. The Western blot analysis was carried out using 40 μg of the cell lysate protein, a primary rabbit antibody against the human BDH2 (catalog no.: PA5-44760; Invitrogen), and a horseradish peroxidase–conjugated goat anti-rabbit secondary antibody. The secondary antibody was detected by measuring enhanced chemiluminescence. The presence of a nonspecific signal (≈30 kDa) is in agreement with the specification of the primary antibody. BDH2, type 2 ( R )-β-hydroxybutyrate dehydrogenase; HEK293T, human embryonic kidney 293T cell line.
Specificity Cas9 Enzyme, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc08914325-327-5-13?v=Addgene+inc
Average 93 stars, based on 1 article reviews
specificity cas9 enzyme - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
PNA Bio Inc recombinant cas9
KEY RESOURCES TABLE
Recombinant Cas9, supplied by PNA Bio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc07233142-705-4-6?v=PNA+Bio+Inc
Average 90 stars, based on 1 article reviews
recombinant cas9 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Lonza nucleofected
KEY RESOURCES TABLE
Nucleofected, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc09663826-56-7-3?v=Lonza
Average 90 stars, based on 1 article reviews
nucleofected - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Rockland Immunochemicals anti cas9 primary antibody
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Anti Cas9 Primary Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pm40054114-105-10-18?v=Rockland+Immunochemicals
Average 90 stars, based on 1 article reviews
anti cas9 primary antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation enhanced specificity cas9-2agreen fluorescent protein (espcas9-2a-gfp)
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Enhanced Specificity Cas9 2agreen Fluorescent Protein (Espcas9 2a Gfp), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pm36191855-267-12-30?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
enhanced specificity cas9-2agreen fluorescent protein (espcas9-2a-gfp) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation espcas9-2a-gfp
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Espcas9 2a Gfp, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pm36686648-63-9-11?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
espcas9-2a-gfp - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
Addgene inc specificity cas9
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Specificity Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pm41422089-164-9-12?v=Addgene+inc
Average 94 stars, based on 1 article reviews
specificity cas9 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp pou5f1 hs00999632 g1
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Gene Exp Pou5f1 Hs00999632 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pm39121651-51-89-74?v=Thermo+Fisher
Average 99 stars, based on 1 article reviews
gene exp pou5f1 hs00999632 g1 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology gasc1 specific crispr cas9 gfp
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Gasc1 Specific Crispr Cas9 Gfp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc07946911-40-7-11?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
gasc1 specific crispr cas9 gfp - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

96
Proteintech speci c primary antibodies
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Speci C Primary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/ppr0214302-78-1-15?v=Proteintech
Average 96 stars, based on 1 article reviews
speci c primary antibodies - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

90
Lonza crispr-cas9 expressing plasmid px458
Fig. 1. Designing and development of the <t>CRISPR-Cas9-based</t> plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Crispr Cas9 Expressing Plasmid Px458, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9+protein/pmc06376486-323-19-31?v=Lonza
Average 90 stars, based on 1 article reviews
crispr-cas9 expressing plasmid px458 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


OTX2 H230L had no abnormal phenotype, and C-terminal variants are tolerated. (A) CRISPR/Cas9 generated Otx2 H230L and multiple by-product variants. (B) Otx2 H230L had no obvious phenotype in either the pituitary gland or the eye. Otx2 L219fs*17 showed anophthalmia/microphthalmia but, however, showed similar pituitary morphology to WT animals. Arrows and arrowheads indicate the pituitary gland and optic nerve, respectively. (C) HE staining of eyes of adult mice. Otx2 H230L had normal eyes, but the retina of Otx2 L219fs*17 was thin. (D, E and F) Pituitary histology of P0 mice. (D) HE staining, (E) GH staining, and (F) LH staining were similar between genotypes.

Journal: European Journal of Endocrinology

Article Title: The phenotypic spectrum associated with OTX2 mutations in humans

doi: 10.1530/EJE-20-1453

Figure Lengend Snippet: OTX2 H230L had no abnormal phenotype, and C-terminal variants are tolerated. (A) CRISPR/Cas9 generated Otx2 H230L and multiple by-product variants. (B) Otx2 H230L had no obvious phenotype in either the pituitary gland or the eye. Otx2 L219fs*17 showed anophthalmia/microphthalmia but, however, showed similar pituitary morphology to WT animals. Arrows and arrowheads indicate the pituitary gland and optic nerve, respectively. (C) HE staining of eyes of adult mice. Otx2 H230L had normal eyes, but the retina of Otx2 L219fs*17 was thin. (D, E and F) Pituitary histology of P0 mice. (D) HE staining, (E) GH staining, and (F) LH staining were similar between genotypes.

Article Snippet: The Otx2 variant alleles were generated by microinjecting enhanced specificity Cas9 protein (30 ng/uL, Integrated DNA Technologies), DNA donor oligo (10 ng/µL, Integrated DNA Technologies), and C77G2 crRNA 10 ng/μL annealed with tracrRNA 15 ng/μL (Integrated DNA Technologies) into fertilized eggs obtained from super-ovulated B6CBAF1 females purchased from the Jackson Laboratory.

Techniques: CRISPR, Generated, Staining

Western blot analysis of BDH2 expression in four Bdh2 -deficient HEK293T clonal cell lines ( Bdh2 -KO) and WT HEK293T cells (WT). The KO clonal cell lines (A12, A15, B9, and B13) were generated by the CRISPR–Cas9 gene-inactivation procedure. The Western blot analysis was carried out using 40 μg of the cell lysate protein, a primary rabbit antibody against the human BDH2 (catalog no.: PA5-44760; Invitrogen), and a horseradish peroxidase–conjugated goat anti-rabbit secondary antibody. The secondary antibody was detected by measuring enhanced chemiluminescence. The presence of a nonspecific signal (≈30 kDa) is in agreement with the specification of the primary antibody. BDH2, type 2 ( R )-β-hydroxybutyrate dehydrogenase; HEK293T, human embryonic kidney 293T cell line.

Journal: The Journal of Biological Chemistry

Article Title: Recharacterization of the mammalian cytosolic type 2 ( R )-β-hydroxybutyrate dehydrogenase as 4-oxo- l -proline reductase (EC 1.1.1.104)

doi: 10.1016/j.jbc.2022.101708

Figure Lengend Snippet: Western blot analysis of BDH2 expression in four Bdh2 -deficient HEK293T clonal cell lines ( Bdh2 -KO) and WT HEK293T cells (WT). The KO clonal cell lines (A12, A15, B9, and B13) were generated by the CRISPR–Cas9 gene-inactivation procedure. The Western blot analysis was carried out using 40 μg of the cell lysate protein, a primary rabbit antibody against the human BDH2 (catalog no.: PA5-44760; Invitrogen), and a horseradish peroxidase–conjugated goat anti-rabbit secondary antibody. The secondary antibody was detected by measuring enhanced chemiluminescence. The presence of a nonspecific signal (≈30 kDa) is in agreement with the specification of the primary antibody. BDH2, type 2 ( R )-β-hydroxybutyrate dehydrogenase; HEK293T, human embryonic kidney 293T cell line.

Article Snippet: This vector encodes an enhanced specificity Cas9 enzyme (a gift from Andrea Németh; Addgene; plasmid no.: 101039) ( ).

Techniques: Western Blot, Expressing, Generated, CRISPR

KEY RESOURCES TABLE

Journal: Developmental cell

Article Title: Cancer Cells Upregulate NRF2 Signaling to Adapt to Autophagy Inhibition

doi: 10.1016/j.devcel.2019.07.010

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Specifically, 200 ng of recombinant Cas9 (PNAbio) was incubated for 10 minutes with 5 ng of each guide RNA (two that target GFP and two that target the gene of interest).

Techniques: Recombinant, Protease Inhibitor, CRISPR, Transfection, Isolation, SYBR Green Assay, Activity Assay, Flow Cytometry, shRNA, Plasmid Preparation

Fig. 1. Designing and development of the CRISPR-Cas9-based plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Plant physiology and biochemistry : PPB

Article Title: Combating aggressive weeds: Reinforcing herbicide resistance in pigeonpea (Cajanus cajan L.) through genome editing.

doi: 10.1016/j.plaphy.2025.109550

Figure Lengend Snippet: Fig. 1. Designing and development of the CRISPR-Cas9-based plant transformation vector for the incorporation of the desired mutations in the wild CcEPSPS gene where A. pCAMBIA1300-based NICTK-2_pCRISPR-Cas9 binary vector harboring the Cas9 expression cassette highlighted with NLS: nuclear localization signal, promoter sequence and restriction sites essential for cloning. B. The schematic representation depicting the standardized pipeline for the selection of the sgRNAs with high efficiency and no off-target activity and cloning of the selected sgRNAs in the NICTK-2_pCRISPR-Cas9 binary vector to develop complete CcEPSPS_NICTK- 2_pCRISPR-Cas9 plant transformation vector. C. Represents the sgRNA cassette where the effective AtU6-29 and AtU3b promoters drive the expression of the selected sequences (pink; highlighted PAM with red) of crRNA with scaffolds and terminator. D. Represents the sequence of the two selected sgRNAs confining the target region of the CcEPSPS gene. E. Represents the CcEPSPS donor repair template harboring the desired mutations in the target region ie., 182G > A (green), 183T > I (red), and 187P > S (blue) which will be utilized for the homology directed repair mechanism and development of mutated CcEPSPS. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The blocked blot was probed with 1:1000 dilution of Rabbit-raised anti-Cas9 primary antibody (specific to Cas9; procured from Rockland, USA) followed by incubation with 1:20000 dilution ratio of Goat anti-Rabbit HRP conjugated secondary antibody for 1H at RT.

Techniques: CRISPR, Transformation Assay, Plasmid Preparation, Expressing, Sequencing, Cloning, Selection, Activity Assay

Fig. 2. A. Representative images of stages in tissue culture of Pigeonpea (i) Seeds (seed coat removed) of pigeonpea on germination media (GM) (ii) Seed germination (iii) Excised embryonic axis (EA) explant on callus induction medium (CIM) (iv) Induction of callus on CIM (v) Initiation of multiple shooting from induced callus on the regeneration medium (REM) (vi) Regenerated shoots on the elongation media (EM) (vii) Rhizogenesis on rooting medium (RM) (viii) Rep resents the in vitro regenerated plants under hardening. B. The schematic representation of standardized protocol for biolistic transformation of the callus with 0.6 μm microcarrier (gold particle) coated with CcEPSPS_NICTK-2_pCRISPR-Cas9 plant transformation vector and donor template. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Journal: Plant physiology and biochemistry : PPB

Article Title: Combating aggressive weeds: Reinforcing herbicide resistance in pigeonpea (Cajanus cajan L.) through genome editing.

doi: 10.1016/j.plaphy.2025.109550

Figure Lengend Snippet: Fig. 2. A. Representative images of stages in tissue culture of Pigeonpea (i) Seeds (seed coat removed) of pigeonpea on germination media (GM) (ii) Seed germination (iii) Excised embryonic axis (EA) explant on callus induction medium (CIM) (iv) Induction of callus on CIM (v) Initiation of multiple shooting from induced callus on the regeneration medium (REM) (vi) Regenerated shoots on the elongation media (EM) (vii) Rhizogenesis on rooting medium (RM) (viii) Rep resents the in vitro regenerated plants under hardening. B. The schematic representation of standardized protocol for biolistic transformation of the callus with 0.6 μm microcarrier (gold particle) coated with CcEPSPS_NICTK-2_pCRISPR-Cas9 plant transformation vector and donor template. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The blocked blot was probed with 1:1000 dilution of Rabbit-raised anti-Cas9 primary antibody (specific to Cas9; procured from Rockland, USA) followed by incubation with 1:20000 dilution ratio of Goat anti-Rabbit HRP conjugated secondary antibody for 1H at RT.

Techniques: In Vitro, Transformation Assay, Plasmid Preparation

Fig. 3. Molecular characterization of putative positive T0 and T1 edited plants. A. Illustrate the amplification with Cas9 specific primer in putative positive T0 plants showing Cas9 integration. B. Amplification with EPSPS target site overlapping primer set1 of the Cas9 positive T0 plants showing desired mutation. C. Illustrate the amplification with EPSPS target site overlapping primer set2 of the Cas9 positive T0 plants showing desired mutation. D. Amplification of a portion spanning the target site of the EPSPS gene from putative positive T0 plants utilized for sequencing. E. Illustrate the amplification with Cas9 specific primers of putative positive T1 plants showing Cas9 integration. F. Amplification of a portion spanning the target site of the EPSPS gene from positive T1 plants. Where, M- 1 kb DNA ladder, NTC- no template control, WT-wild type, PC- positive control, and WC- water control. G. Representative Southern blot analysis of established T1 transformants showing the single copy number of Cas9 gene in screened transgenic pigeonpea plants. These observations were obtained by the digestion of genomic DNA from eight T1 plants using restriction enzyme EcoRV and Cutsmart 2 buffer obtained from NEB. Lane M 100 ng DNA molecular weight marker III, Digoxigenin labeled, lane S1-8 20 μg genomic DNA, EcoRV, lane WT 20 μg genomic DNA of untransformed plant, EcoRV, lane PC 5 μg positive control plasmid DNA. H. Representative Western blot analysis of established T1 transformants showing Cas9 protein expression in T1 edited pigeonpea plants. These observations were obtained by the total protein extraction from eight edited plants using Cas9 specific primary antibody. Where in S1-8 lane, 40–45 μg/ml of plant extracts were loaded and for positive control (PC) 1ug/ul Cas9 protein was loaded. The marker used in the lane M was of size 10–180 KDa.

Journal: Plant physiology and biochemistry : PPB

Article Title: Combating aggressive weeds: Reinforcing herbicide resistance in pigeonpea (Cajanus cajan L.) through genome editing.

doi: 10.1016/j.plaphy.2025.109550

Figure Lengend Snippet: Fig. 3. Molecular characterization of putative positive T0 and T1 edited plants. A. Illustrate the amplification with Cas9 specific primer in putative positive T0 plants showing Cas9 integration. B. Amplification with EPSPS target site overlapping primer set1 of the Cas9 positive T0 plants showing desired mutation. C. Illustrate the amplification with EPSPS target site overlapping primer set2 of the Cas9 positive T0 plants showing desired mutation. D. Amplification of a portion spanning the target site of the EPSPS gene from putative positive T0 plants utilized for sequencing. E. Illustrate the amplification with Cas9 specific primers of putative positive T1 plants showing Cas9 integration. F. Amplification of a portion spanning the target site of the EPSPS gene from positive T1 plants. Where, M- 1 kb DNA ladder, NTC- no template control, WT-wild type, PC- positive control, and WC- water control. G. Representative Southern blot analysis of established T1 transformants showing the single copy number of Cas9 gene in screened transgenic pigeonpea plants. These observations were obtained by the digestion of genomic DNA from eight T1 plants using restriction enzyme EcoRV and Cutsmart 2 buffer obtained from NEB. Lane M 100 ng DNA molecular weight marker III, Digoxigenin labeled, lane S1-8 20 μg genomic DNA, EcoRV, lane WT 20 μg genomic DNA of untransformed plant, EcoRV, lane PC 5 μg positive control plasmid DNA. H. Representative Western blot analysis of established T1 transformants showing Cas9 protein expression in T1 edited pigeonpea plants. These observations were obtained by the total protein extraction from eight edited plants using Cas9 specific primary antibody. Where in S1-8 lane, 40–45 μg/ml of plant extracts were loaded and for positive control (PC) 1ug/ul Cas9 protein was loaded. The marker used in the lane M was of size 10–180 KDa.

Article Snippet: The blocked blot was probed with 1:1000 dilution of Rabbit-raised anti-Cas9 primary antibody (specific to Cas9; procured from Rockland, USA) followed by incubation with 1:20000 dilution ratio of Goat anti-Rabbit HRP conjugated secondary antibody for 1H at RT.

Techniques: Amplification, Mutagenesis, Sequencing, Control, Positive Control, Southern Blot, Transgenic Assay, Molecular Weight, Marker, Labeling, Plasmid Preparation, Western Blot, Expressing, Protein Extraction

Fig. 5. The molecular characterization of T2 edited plants. A. Illustrate the amplification with Cas9 specific primers of T2 edited plants showing Cas9 integration (T2.1

Journal: Plant physiology and biochemistry : PPB

Article Title: Combating aggressive weeds: Reinforcing herbicide resistance in pigeonpea (Cajanus cajan L.) through genome editing.

doi: 10.1016/j.plaphy.2025.109550

Figure Lengend Snippet: Fig. 5. The molecular characterization of T2 edited plants. A. Illustrate the amplification with Cas9 specific primers of T2 edited plants showing Cas9 integration (T2.1

Article Snippet: The blocked blot was probed with 1:1000 dilution of Rabbit-raised anti-Cas9 primary antibody (specific to Cas9; procured from Rockland, USA) followed by incubation with 1:20000 dilution ratio of Goat anti-Rabbit HRP conjugated secondary antibody for 1H at RT.

Techniques: Amplification

Fig. 6. Physiological analysis of WT, TC and edited T2 plants under glyphosate treatment. A. Seed germination analysis: seeds of WT and T2 generation edited seeds were germinated on germination medium supplemented with gradually increasing concentration of glyphosate (0–50 mM) in a glass jar under controlled tissue culture conditions. Additionally, the effect of 4 mM of glyphosate on the growth of edited (T2 generation) and WT seeds displayed that all the edited seeds germinated while WT seeds did not germinate. Data was recorded after two week of incubation. B. Glyphosate spray analysis: 42-days-old T2 plants and C. 28-days-old T2 plants were sprayed with 6 ml/L commercial glyphosate (Roundup: 41.0% w/v; Monsanto Inc., Montreal, QC, Canada) under controlled greenhouse conditions (RH = 85%; Temp. = 28±2 ◦C). The data was recorded after one week. D. Post glyphosate treatment the edited plants were allowed to grow till maturity and the recovered Cas9- free T2 plants displayed optimum growth. E. Weed competition assay: the WT and edited plants seeds were germinated along with associated weeds on a vermiculite tray and they were sprayed with 6 ml/L Roundup solution and after one week only edited plants survived.

Journal: Plant physiology and biochemistry : PPB

Article Title: Combating aggressive weeds: Reinforcing herbicide resistance in pigeonpea (Cajanus cajan L.) through genome editing.

doi: 10.1016/j.plaphy.2025.109550

Figure Lengend Snippet: Fig. 6. Physiological analysis of WT, TC and edited T2 plants under glyphosate treatment. A. Seed germination analysis: seeds of WT and T2 generation edited seeds were germinated on germination medium supplemented with gradually increasing concentration of glyphosate (0–50 mM) in a glass jar under controlled tissue culture conditions. Additionally, the effect of 4 mM of glyphosate on the growth of edited (T2 generation) and WT seeds displayed that all the edited seeds germinated while WT seeds did not germinate. Data was recorded after two week of incubation. B. Glyphosate spray analysis: 42-days-old T2 plants and C. 28-days-old T2 plants were sprayed with 6 ml/L commercial glyphosate (Roundup: 41.0% w/v; Monsanto Inc., Montreal, QC, Canada) under controlled greenhouse conditions (RH = 85%; Temp. = 28±2 ◦C). The data was recorded after one week. D. Post glyphosate treatment the edited plants were allowed to grow till maturity and the recovered Cas9- free T2 plants displayed optimum growth. E. Weed competition assay: the WT and edited plants seeds were germinated along with associated weeds on a vermiculite tray and they were sprayed with 6 ml/L Roundup solution and after one week only edited plants survived.

Article Snippet: The blocked blot was probed with 1:1000 dilution of Rabbit-raised anti-Cas9 primary antibody (specific to Cas9; procured from Rockland, USA) followed by incubation with 1:20000 dilution ratio of Goat anti-Rabbit HRP conjugated secondary antibody for 1H at RT.

Techniques: Concentration Assay, Incubation, Competitive Binding Assay